Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

EU project confirms Europe's excellence in migraine research

07.11.2007
An EU-funded project on migraines has not only taken researchers a step closer to understanding the causes of these incapacitating attacks, but has created a critical mass, reinforcing Europe's reputation of excellence in this field, and reassuring migraine sufferers that their condition is being taken seriously.

Over 12% of the world's population suffer from migraines, with women making up two-thirds of sufferers. The attacks are not only highly unpleasant for sufferers, but are also costly for employers and health services. Annual costs are estimated at €10 billion for the EU alone.

Although the problem is widespread, the available treatments are unsuccessful in more than half of patients. The migraine community is therefore desperate for possible treatments, and has demonstrated this by participating in EUROHEAD's research.

Coordinators of the recently-concluded EU-funded project EUROHEAD spoke to CORDIS News about the discoveries made in the project and the impact that it has had on the migraine research community worldwide.

A cure for migraines is still some way off, but the EUROHEAD team does now have a much better understanding of how genes are involved in the triggering of a migraine, and how the trigger threshold can be reduced.

There is compelling evidence that cortical spreading depression (CSD) is responsible for the 'aura', the visual disturbances that often accompany migraines. The EUROHEAD team now believes that it could also be responsible for the onset of migraines themselves.

Several thousand migraine patients participated in the research, including twins and families in which migraines are common. Crucial to the success of the project was the involvement of people who suffer from a monogenic subtype of migraine, in which one sole gene is responsible for the condition. Five or six years ago there was just one pool of patients with the monogenic migraine subtype. The EUROHEAD team has now identified far more families in which the condition runs, and has also identified new syndromes.

Much of the research was done using cellular models, but animal models and human volunteers were also involved. Cellular models enabled the team to see what effects the genes had on cells at microscopic level. When investigating how the cells interact, the animal models were needed. 'We could never have done this if we had stuck to single cells. The two models were complimentary,' explains Dr Arn van den Maagdenberg of Leiden University Medical Centre in the Netherlands.

Brave volunteers in Denmark had an attack triggered by a team at Glostrup University Hospital using nitric oxide. The method developed in Glostrup is successful in triggering migraines in 60% to 70% of sufferers. Asked about these volunteers' readiness to have a migraine triggered in the name of science, Principal Investigator Michel Ferrari was very positive: 'The migraine population as a whole is very happy with initiatives like this. They feel they are being taken seriously. It has been established that this is a real disease,' he says.

While EUROHEAD has shown migraine-sufferers that they are being taken seriously, it has also indicated to the world that Europe should be taken seriously as a centre of excellence for migraine research. 'Europe is already the centre of excellence for migraine research. It is striking that, in other medical areas, the US is leading, but not in this area,' says Dr Ferrari. Moreover, most of the important research groups in this field were members of the EUROHEAD consortium.

The team has been contacted by researchers in every continent interested in collaborating on future research. Many have even sent genetic material from new families of migraine-sufferers. The EUROHEAD team is following up on the invitations that it has received, and many joint publications are in the pipeline.

EUROHEAD is currently experiencing what Dr van den Maagdenberg refers to as the 'magnet effect'. 'Everybody's looking at EUROHEAD as the experts on migraines,' he said.

Dr van den Maagdenberg welcomes the critical mass, the integration of research teams and the momentum created by EUROHEAD. When the right call is published under the EU's Seventh Framework Programme (FP7), the team will apply for further funding with the ultimate aim of finding a cure for the migraine.

Virginia Mercouri | alfa
Further information:
http://www.eurohead.org/
http://cordis.europa.eu/news

More articles from Health and Medicine:

nachricht Researchers image atomic structure of important immune regulator
11.12.2018 | Brigham and Women's Hospital

nachricht Potential seen for tailoring treatment for acute myeloid leukemia
10.12.2018 | University of Washington Health Sciences/UW Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Topological material switched off and on for the first time

Key advance for future topological transistors

Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...

Im Focus: Researchers develop method to transfer entire 2D circuits to any smooth surface

What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.

Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...

Im Focus: Three components on one chip

Scientists at the University of Stuttgart and the Karlsruhe Institute of Technology (KIT) succeed in important further development on the way to quantum Computers.

Quantum computers one day should be able to solve certain computing problems much faster than a classical computer. One of the most promising approaches is...

Im Focus: Substitute for rare earth metal oxides

New Project SNAPSTER: Novel luminescent materials by encapsulating phosphorescent metal clusters with organic liquid crystals

Nowadays energy conversion in lighting and optoelectronic devices requires the use of rare earth oxides.

Im Focus: A bit of a stretch... material that thickens as it's pulled

Scientists have discovered the first synthetic material that becomes thicker - at the molecular level - as it is stretched.

Researchers led by Dr Devesh Mistry from the University of Leeds discovered a new non-porous material that has unique and inherent "auxetic" stretching...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

New Plastics Economy Investor Forum - Meeting Point for Innovations

10.12.2018 | Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

Expert Panel on the Future of HPC in Engineering

03.12.2018 | Event News

 
Latest News

Electronic evidence of non-Fermi liquid behaviors in an iron-based superconductor

11.12.2018 | Physics and Astronomy

Topological material switched off and on for the first time

11.12.2018 | Materials Sciences

NIST's antenna evaluation method could help boost 5G network capacity and cut costs

11.12.2018 | Information Technology

VideoLinks
Science & Research
Overview of more VideoLinks >>>